Financial Planning and Analysis Associate Director

Job Description

Position:
Financial Planning & Analysis Associate Director

50 Northern Ave, Boston, Massachusetts, 02210

1

• Provide financial direction and strategic insight to functional leaders, defining and delivering short term and long-term goals, including identification of key value drivers and Business KPIs.
• Provide strategic decision support, influencing decisions and identifying opportunities to invest, save costs, and mitigate risks on a global basis.
• Lead financial planning process for areas of responsibility including budget, forecast, and long‑range plan to provide meaningful forward‑looking direction, develop key scenarios, and identify key risks and uncertainties, planning for potential mitigation.
• Lead financial performance management for areas of responsibility, including monthly accruals, forecast, and operating review, focusing on understanding the key drivers of short‑term performance and communicating the range of possible outcomes.
• Design, enhance, and maintain business valuation and cost of goods sold financial models for areas of responsibility, providing COGs and gross margin analysis and opportunities for cost improvement at launch and long‑term.
• Partner within FP&A and with accounting, DTE, and HR to ensure there is clear ownership and management of the deliverables from those teams and that finance services are delivered seamlessly to the business.
• Ensure financial integrity and robust corporate governance and compliance of financial aspects for areas of responsibility.
• Telecommuting permitted up to 40%.

Employer will accept a Bachelor's degree in Business Administration, Finance, Accounting or a related field and 8 years of experience in the job offered or in a Financial Planning & Analysis Associate Director‑related occupation.

• Experience calculating Cost of Goods Sold, the manufacturing costing, for biologics products in the pharmaceutical industry. Understanding of the overall pharmaceutical manufacturing and supply chain expenses. Experience in building financial models to assess the manufacturing network strategy, which is key to deciding and determining the geographical location of each supplier, risks associated with manufacturing decisions, and implications from a geopolitical and costs, impact in gross margin, point of view.
• Experience with investment of capital expenses (Cap Ex) that are significant in terms of materiality in the pharmaceutical industry, and business partnering with the executive team.
• Strong skills utilizing MS Office and financial software applications including Oracle Hyperion to report and consolidate data. Experience building automation in financial software tools including Power BI to create automated dashboards.
• Experience using Inventory Management Systems including Oracle Inventory Management to measure inventory levels.
• Ability to coordinate budget and forecast financial cycles which consists of assessing the future expenses for manufacturing and supply chain. This includes consolidating the data and numbers and challenging different stakeholder assumptions. Experience assessing the future expenses and investments required for the company in the next fiscal year or next 10 years, the long rate plan.
• Ability to coordinate the Cost of Goods Sold (COGS), which includes assessing the manufacturing cost of the product portfolio of the biologics business unit. Experience leveraging COGS to assess the profitability of products and perform strategic financial calculations for the company. Experience using COGS to measure future investments in the company portfolio.
• Ability to lead and drive change in developing business environments and tight deadlines across multiple zones.
• Experience conducting portfolio analysis, valuation, and ROI/ROIC. Strong analytical skills used in forecast cycle variance versus actual expenses is necessary to identify if expenses are higher or lower versus expectations and to anticipate any company risk or opportunity.
• Experience analyzing manufacturing cost to determine future biologics portfolio COGS in order to understand drug substance performance and overhead costing. Experience…